[go: up one dir, main page]

FI933753L - Neuroleptiska perhydro-1h-pyrido(1,2-a)-pyraziner - Google Patents

Neuroleptiska perhydro-1h-pyrido(1,2-a)-pyraziner Download PDF

Info

Publication number
FI933753L
FI933753L FI933753A FI933753A FI933753L FI 933753 L FI933753 L FI 933753L FI 933753 A FI933753 A FI 933753A FI 933753 A FI933753 A FI 933753A FI 933753 L FI933753 L FI 933753L
Authority
FI
Finland
Prior art keywords
pyraziner
pyrido
perhydro
neuroleptic
neuroleptic perhydro
Prior art date
Application number
FI933753A
Other languages
English (en)
Other versions
FI933753A0 (fi
FI105030B (fi
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933753L publication Critical patent/FI933753L/fi
Publication of FI933753A0 publication Critical patent/FI933753A0/fi
Priority to FI990433A priority Critical patent/FI990433A0/fi
Application granted granted Critical
Publication of FI105030B publication Critical patent/FI105030B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI933753A 1991-02-27 1993-08-26 Menetelmä terapeuttisesti käyttökelpoisten raseemisten tai optisesti aktiivisten 2-(bentso[d]isoksatsol- ja -iso-tiatsol-3-yyli)-perhydro-1H-pyrido[1,2-a]-pyratsiinijohdannaisten valmistamiseksi FI105030B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI990433A FI990433A0 (fi) 1991-02-27 1999-03-01 Neuroleptisiä perhydro-1H-pyrido(1,2-a)pyratsiineja

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US66179191 1991-02-27
US07/661,791 US5157034A (en) 1991-02-27 1991-02-27 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
PCT/US1991/008378 WO1992015580A1 (en) 1991-02-27 1991-11-18 NEUROLEPTIC PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINES
US9108378 1991-11-18

Publications (3)

Publication Number Publication Date
FI933753L true FI933753L (fi) 1993-08-26
FI933753A0 FI933753A0 (fi) 1993-08-26
FI105030B FI105030B (fi) 2000-05-31

Family

ID=24655130

Family Applications (3)

Application Number Title Priority Date Filing Date
FI933753A FI105030B (fi) 1991-02-27 1993-08-26 Menetelmä terapeuttisesti käyttökelpoisten raseemisten tai optisesti aktiivisten 2-(bentso[d]isoksatsol- ja -iso-tiatsol-3-yyli)-perhydro-1H-pyrido[1,2-a]-pyratsiinijohdannaisten valmistamiseksi
FI20000354A FI112865B (fi) 1991-02-27 2000-02-17 Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset
FI20030361A FI114214B (fi) 1991-02-27 2003-03-11 Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset

Family Applications After (2)

Application Number Title Priority Date Filing Date
FI20000354A FI112865B (fi) 1991-02-27 2000-02-17 Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset
FI20030361A FI114214B (fi) 1991-02-27 2003-03-11 Perhydro-1H-pyrido[1,2-a]pyratsiinijohdannaiset

Country Status (24)

Country Link
US (1) US5157034A (fi)
EP (1) EP0573467B1 (fi)
JP (1) JP2546770B2 (fi)
KR (1) KR0163413B1 (fi)
AT (1) ATE123284T1 (fi)
AU (1) AU652422B2 (fi)
CA (2) CA2163274C (fi)
DE (2) DE69110135T2 (fi)
DK (1) DK0573467T3 (fi)
ES (1) ES2073914T3 (fi)
FI (3) FI105030B (fi)
HU (1) HU216637B (fi)
IE (1) IE67190B1 (fi)
IL (2) IL112325A (fi)
MX (1) MX9200803A (fi)
MY (1) MY108185A (fi)
NO (1) NO300847B1 (fi)
NZ (1) NZ241739A (fi)
PT (1) PT100160B (fi)
RU (1) RU2090565C1 (fi)
TW (1) TW207540B (fi)
WO (1) WO1992015580A1 (fi)
YU (1) YU48311B (fi)
ZA (1) ZA921405B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69218414T2 (de) * 1991-02-27 1998-01-22 Pfizer Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten
ES2137986T3 (es) * 1992-06-16 2000-01-01 Pfizer Procedimiento y productos intermedios para agentes ansioliticos bis-aza-biciclicos.
US6231833B1 (en) 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
AU681310B2 (en) * 1994-09-30 1997-08-21 Pfizer Inc. 2,7-substituted octahydro-1h-pyrido{1,2-a}pyrazine derivatives
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
WO2004081007A1 (en) * 2003-03-12 2004-09-23 Pfizer Products Inc. Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
ES2563304T3 (es) * 2003-04-24 2016-03-14 Incyte Holdings Corporation Derivados azaespiro alcano como inhibidores de metaloproteasas
WO2007143600A2 (en) * 2006-06-05 2007-12-13 Incyte Corporation Sheddase inhibitors combined with cd30-binding immunotherapeutics for the treatment of cd30 positive diseases
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4681938A (en) * 1984-08-27 1987-07-21 Ciba-Geigy Corporation Novel polycyclic hydrazones of rifamycins, their manufacture, and their pharmaceutical compositions for treating tuberculosis
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents

Also Published As

Publication number Publication date
EP0573467B1 (en) 1995-05-31
YU48311B (sh) 1998-05-15
RU2090565C1 (ru) 1997-09-20
DE69110135T2 (de) 1995-10-19
CA2163274C (en) 1999-02-09
NO300847B1 (no) 1997-08-04
EP0573467A1 (en) 1993-12-15
FI114214B (fi) 2004-09-15
KR930703315A (ko) 1993-11-29
AU652422B2 (en) 1994-08-25
IE920601A1 (en) 1992-09-09
ATE123284T1 (de) 1995-06-15
HU9302427D0 (en) 1993-11-29
NO933049D0 (no) 1993-08-26
NO933049L (no) 1993-08-26
TW207540B (fi) 1993-06-11
HU216637B (hu) 1999-07-28
CA2101518C (en) 1997-11-25
IE67190B1 (en) 1996-03-06
PT100160B (pt) 1999-09-30
MY108185A (en) 1996-08-30
FI20030361L (fi) 2003-03-11
DK0573467T3 (da) 1995-10-09
ES2073914T3 (es) 1995-08-16
US5157034A (en) 1992-10-20
IL112325A (en) 1997-08-14
YU19892A (sh) 1994-11-15
ZA921405B (en) 1993-08-26
DE9190206U1 (de) 1993-10-14
AU1259992A (en) 1992-10-06
IL112325A0 (en) 1995-03-30
MX9200803A (es) 1992-08-31
HUT66965A (en) 1995-01-30
NZ241739A (en) 1994-07-26
PT100160A (pt) 1993-05-31
JP2546770B2 (ja) 1996-10-23
FI112865B (fi) 2004-01-30
JPH06500120A (ja) 1994-01-06
CA2163274A1 (en) 1992-08-28
KR0163413B1 (ko) 1998-12-01
IL101021A (en) 1996-03-31
DE69110135D1 (de) 1995-07-06
FI933753A0 (fi) 1993-08-26
FI20000354L (fi) 2000-02-17
FI105030B (fi) 2000-05-31
WO1992015580A1 (en) 1992-09-17
CA2101518A1 (en) 1992-08-28

Similar Documents

Publication Publication Date Title
FI933803L (fi) 1-azabicyklo/3.2.2/nonan-3-aminderivat
DE122006000020I1 (de) Aerosolpraparate.
FI923314L (fi) Substituerade cyklopropylamino-1,3,5-triaziner
FI914657A0 (fi) Digitalt audiointerface i gsm -anordning.
FI921435A0 (fi) Skydd foer saenkpump i svaora foer- haollanden.
MX9205306A (es) 3-feniluracilos sustituidos
FI922759A0 (fi) Loesningsmedelskompositioner foer anvaendning i tryckkaensligt kopieringspapper.
MX9204547A (es) Neristatina 1.
FI922095A0 (fi) Substituerade karboxylsyraderivat.
FI923724A0 (fi) Monterings- och distansanordning foer braenslestavarna i en kokvattenreaktor.
FI924355A0 (fi) Substituerade imidazolylpropensyraderivat.
FI912922L (fi) Anordning foer tilltraede i flexibla behaollare.
FI933753L (fi) Neuroleptiska perhydro-1h-pyrido(1,2-a)-pyraziner
FI922180A0 (fi) Tuggummi innehaollande tuggummibas i en valsningsblandning.
FI923290L (fi) Imidazo(2,1-b)bensotiazol-3-acetamidderivat
FI920094A0 (fi) Bettjusteringsanordning foer betthuvud i traeflishuggare.
FI941377L (fi) Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja
FI912307A (fi) Motkniv foer anvaendning i en flishugg.
FI920998A0 (fi) Skaermad hytt i modulkonstruktion.
FI915337A0 (fi) Elektroniskt knaeppningssvar foer en folieknappsats i en mobiltelefon.
FI920443A0 (fi) Polyolefinfilmer i flera skikt.
FI923542L (fi) Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner
NO922732D0 (no) 3,4-dehydropiperidinderivater
FI922714A0 (fi) Anordning i en sf6-isolerad hoegspaenningslindningskopplare.
FI916087A0 (fi) Anordning i en produktionslinje foer mineralull.

Legal Events

Date Code Title Description
MA Patent expired